GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (ASX:PME) » Definitions » Forward PE Ratio

Pro Medicus (ASX:PME) Forward PE Ratio : 121.95 (As of May. 13, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pro Medicus Forward PE Ratio?

Pro Medicus's Forward PE Ratio for today is 121.95.

Pro Medicus's PE Ratio without NRI for today is 170.14.

Pro Medicus's PE Ratio for today is 170.14.


Pro Medicus Forward PE Ratio Historical Data

The historical data trend for Pro Medicus's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus Forward PE Ratio Chart

Pro Medicus Annual Data
Trend 2018-12 2019-12 2020-12 2021-12 2022-12 2023-12 2024-05
Forward PE Ratio
80.00 101.01 120.48 151.52 89.29 123.46 121.95

Pro Medicus Semi-Annual Data
2018-09 2018-12 2019-03 2019-06 2019-09 2019-12 2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 90.09 80.00 86.96 147.06 119.05 101.01 59.17 90.09 96.15 120.48 123.46 133.33 136.99 151.52 81.97 81.30 79.37 89.29 95.24 97.09 114.94 123.46 109.89

Competitive Comparison of Pro Medicus's Forward PE Ratio

For the Health Information Services subindustry, Pro Medicus's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus's Forward PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Pro Medicus's Forward PE Ratio falls into.



Pro Medicus Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Pro Medicus  (ASX:PME) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Pro Medicus Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Pro Medicus's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus (ASX:PME) Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.